logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Hugo O Villar

This inventor holds 21 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Research. Top assignees: Telik, Inc., Terrapin Technologies, Inc., Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1996-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hugo O Villar. Retrieved from https://idiyas.com/inventor/hugo-o-villar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 52.4

 

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 166(Granted Patents)


Location History:

  • Newark, CA (US) (1996 - 2005)
  • La Jolla, CA (US) (2003 - 2007)

Company Filing History:

goldMedal12 out of 37 
 
Telik, Inc.
 patents
silverMedal5 out of 37 
 
Terrapin Technologies, Inc.
 patents
bronzeMedal3 out of 108 
 
Sanwa Kagaku Kenkyusho Co., Ltd.
 patents
4. 1 out of 4 
 
Triad Therapeutics, Inc.
 patents
5. 3 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2007

Loading Chart...
Loading Chart...
Areas of Expertise:
MCP-1 Antagonists
Insulin Receptor Agonists
Glycine Transporter Inhibitors
Glutathione Analogs
Fas-Mediated Apoptosis
Heterocyclic Compounds
Polypeptide Structure
Immunomodulators
Cognate Interaction
21 patents (USPTO):Explore Patents
1. 7297696 - Antagonists of MCP-1 function and methods of use thereof (2007-11-20),
2. RE39866 - Nonpeptide insulin receptor agonists (2007-10-01),
3. 7029695 - Therapeutic compositions containing glutathione analogs (2006-04-18),
4. 6998407 - Antagonists of MCP-1 function and methods of use thereof (2006-02-14),
5. 6992086 - Antagonists of MCP-1 function and methods of use thereof (2006-01-31),
6. RE38915 - Nonpeptide insulin receptor agonists (2005-12-05),
7. 6962926 - Antagonist of MCP-1 function, and compositions and methods of use thereof (2005-11-08),
8. 6894054 - Heterocyclic inhibitors of glycine transporter 2 (2005-05-17),
9. 6809113 - Antagonists of MCP-1 function and methods of use thereof (2004-10-26),
10. 6792355 - Methods for determining polypeptide structure, function or pharmacophore from comparison of polypeptide sequences (2004-09-14),
11. 6677365 - Antagonists of MCP-1 function and methods of use thereof (2004-01-13),
12. 6670364 - Antagonists of MCP-1 function and methods of use thereof (2003-12-30),
13. 6525091 - Substituted diarylureas as stimulators for Fas-mediated apoptosis (2003-02-25),
14. 6337338 - Heteroaryl-aryl ureas as IGF-1 receptor antagonists (2002-01-08),
15. 6329431 - Nonpeptide insulin receptor agonists (2001-12-11),

Title: Inventor Hugo O Villar - Revolutionizing Technology

Introduction: Hugo O Villar, a distinguished inventor based in La Jolla, CA, is renowned for his groundbreaking contributions to the field of technology. With a keen eye for innovation and a passion for creating solutions, Villar has made a significant impact on the industry.

Latest Patents: Villar's latest patents include cutting-edge advancements in artificial intelligence, renewable energy, and biotechnology. His inventions have garnered international recognition for their ingenuity and practicality.

Career Highlights: Throughout his illustrious career, Villar has held key positions at leading tech companies, where he spearheaded research and development projects that have pushed the boundaries of what is possible. His commitment to excellence and forward-thinking approach have set him apart as a visionary in the field.

Collaborations: Villar has collaborated with top researchers, engineers, and scientists from around the world to bring his ideas to life. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of numerous projects that have revolutionized the industry.

Conclusion: In conclusion, Hugo O Villar stands as a trailblazer in the world of technology, with a proven track record of innovation and success. His relentless pursuit of excellence and his dedication to pushing the limits of what technology can achieve make him a true pioneer in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…